CoChat
Sign Up
Cited by 159

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

Lim, Kian-Huat, Counter, Christopher M.·2005·Cancer Cell
DOI 10.1016/j.ccr.2005.10.014
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2005.10.014

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Bender, 1987, Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region, J. Virol., 61, 1639, 10.1128/JVI.61.5.1639-1646.1987 · DOI
  2. Bos, 1989, ras oncogenes in human cancer: a review, Cancer Res., 49, 4682
  3. Brummelkamp, 2002, Stable suppression of tumorigenicity by virus-mediated RNA interference, Cancer Cell, 2, 243, 10.1016/S1535-6108(02)00122-8 · DOI · Paper page
  4. Burridge, 2004, Rho and Rac take center stage, Cell, 116, 167, 10.1016/S0092-8674(04)00003-0 · DOI
  5. Chin, 1999, Essential role for oncogenic Ras in tumour maintenance, Nature, 400, 468, 10.1038/22788 · DOI
  6. Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 · DOI · Paper page
  7. Dajee, 2002, Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation, Oncogene, 21, 1527, 10.1038/sj.onc.1205287 · DOI
  8. Feig, 2003, Ral-GTPases: approaching their 15 minutes of fame, Trends Cell Biol., 13, 419, 10.1016/S0962-8924(03)00152-1 · DOI · Paper page
  9. Giuriato, 2004, Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer, Semin. Cancer Biol., 14, 3, 10.1016/j.semcancer.2003.11.002 · DOI
  10. Hamad, 2002, Distinct requirements for Ras oncogenesis in human versus mouse cells, Genes Dev., 16, 2045, 10.1101/gad.993902 · DOI
  11. Ikehara, 2005, BRAF mutation associated with dysregulation of apoptosis in human colorectal neoplasms, Int. J. Cancer, 115, 943, 10.1002/ijc.20957 · DOI
  12. Kulik, 1997, Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt, Mol. Cell. Biol., 17, 1595, 10.1128/MCB.17.3.1595 · DOI
  13. Lim, 2004, Leveling the playing field, Mol. Cell, 15, 491, 10.1016/j.molcel.2004.08.014 · DOI
  14. Lim, 2005, Activation of RalA is critical for Ras-induced tumorigenesis of human cells, Cancer Cell, 7, 533, 10.1016/j.ccr.2005.04.030 · DOI · Paper page
  15. Luo, 2003, Targeting the PI3K-Akt pathway in human cancer: Rationale and promise, Cancer Cell, 4, 257, 10.1016/S1535-6108(03)00248-4 · DOI · Paper page
  16. Mansour, 1994, Transformation of mammalian cells by constitutively active MAP kinase kinase, Science, 265, 966, 10.1126/science.8052857 · DOI
  17. McFarlin, 2003, Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane, Carcinogenesis, 24, 1149, 10.1093/carcin/bgg045 · DOI
  18. McFarlin, 2003, Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas, Carcinogenesis, 24, 99, 10.1093/carcin/24.1.99 · DOI
  19. Morrison, 1997, The complexity of Raf-1 regulation, Curr. Opin. Cell Biol., 9, 174, 10.1016/S0955-0674(97)80060-9 · DOI
  20. Mueller, 2004, Friends or foes—bipolar effects of the tumour stroma in cancer, Nat. Rev. Cancer, 4, 839, 10.1038/nrc1477 · DOI
  21. O’Hayer, K.M., and Counter, C.M. (2005). A genetically defined normal human somatic cell system to study ras oncogenesis in vitro and in vivo. In Methods in Enzymology, Volume 407, Regulators and Effectors of Small GTPases, Part H: Ras Family, W.E. Balch, C.J. Der, A. Hall, eds. (San Diego, CA: Academic Press), in press.
  22. Pelengaris, 2002, Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression, Cell, 109, 321, 10.1016/S0092-8674(02)00738-9 · DOI
  23. Rangarajan, 2003, Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice, Nat. Rev. Cancer, 3, 952, 10.1038/nrc1235 · DOI
  24. Rangarajan, 2004, Species- and cell type-specific requirements for cellular transformation, Cancer Cell, 6, 171, 10.1016/j.ccr.2004.07.009 · DOI
  25. Rodriguez-Viciana, 1997, Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras, Cell, 89, 457, 10.1016/S0092-8674(00)80226-3 · DOI
  26. Shields, 2000, Understanding Ras: ‘it ain’t over ’til it's over’, Trends Cell Biol., 10, 147, 10.1016/S0962-8924(00)01740-2 · DOI
  27. Singh, 2004, Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation, Oncogene, 23, 9369, 10.1038/sj.onc.1208182 · DOI
  28. Stanton, 1989, Definition of the human raf amino-terminal regulatory region by deletion mutagenesis, Mol. Cell. Biol., 9, 639, 10.1128/MCB.9.2.639 · DOI
  29. Tarutani, 2003, Inducible activation of Ras and Raf in adult epidermis, Cancer Res., 63, 319
  30. Ulku, 2003, Ras signaling, deregulation of gene expression and oncogenesis, Cancer Treat. Res., 115, 189, 10.1007/0-306-48158-8_8 · DOI
  31. Vivanco, 2002, The phosphatidylinositol 3-kinase AKT pathway in human cancer, Nat. Rev. Cancer, 2, 489, 10.1038/nrc839 · DOI
  32. White, 1995, Multiple Ras functions can contribute to mammalian cell transformation, Cell, 80, 533, 10.1016/0092-8674(95)90507-3 · DOI
  33. White, 1996, A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation, J. Biol. Chem., 271, 16439, 10.1074/jbc.271.28.16439 · DOI
  34. Wolthuis, 1997, Stimulation of gene induction and cell growth by the Ras effector Rlf, EMBO J., 16, 6748, 10.1093/emboj/16.22.6748 · DOI
  35. Wolthuis, 1998, Activation of the small GTPase Ral in platelets, Mol. Cell. Biol., 18, 2486, 10.1128/MCB.18.5.2486 · DOI
  36. Yan, 1998, Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase, J. Biol. Chem., 273, 24052, 10.1074/jbc.273.37.24052 · DOI

Cited by

Sorted by citations

See all 159

Metadata

Authors
Lim, K.-H., & Counter, C. M.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2005-11
Volume
8
Issue
5
Pages
381-392
ISSN
1535-6108
DOI
10.1016/j.ccr.2005.10.014
Cited by
159
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review